Maya Matthews
Lobbying Activity
Meeting with European Patients' Forum (EPF)
24 Nov 2025 · Discussion on EPF’s current activities and planned actions with respect to the Health Technology Assessment Regulation (HTAR) implementation
Meeting with European Organisation for Research and Treatment of Cancer
6 Nov 2025 · Involvement of clinical experts taking part in joint clinical assessments and scientific consultations under the EU Health Technology Assessment (HTA) Regulation
Meeting with
22 Oct 2025 · Exchange of views on joint clinical assessment and joint scientific consultations under the HTA Regulation.
Meeting
7 Oct 2025 · Discussion and exchange of views on the application of the Health Technology Assessment Regulation and the international health policy framework
Meeting with EUROPEAN ORGANISATION FOR RARE DISEASES
29 Sept 2025 · Involvement of individual experts, including patients, taking part in joint clinical assessments and scientific consultations under the EU HTA Regulation, as well as capacity-building activities funded by the EU4Health
Meeting with Ultragenyx Europe Gmbh
23 Sept 2025 · Understanding the identification of clinical experts to participate in joint scientific consultations and joint clinical assessments under the EU Regulation on health technology assessment
Meeting with Università Cattolica del Sacro Cuore
25 Jul 2025 · Introduction to the EDiHTA project
Meeting with
24 Jul 2025 · Discuss the input received during the public feedback on the draft Implementing Regulation on joint clinical assessments for medical devices and in vitro diagnostic medical devices
Meeting with European Federation of Pharmaceutical Industries and Associations
3 Jul 2025 · Discussion on implementation of the HTA Regulation with EFPIA HTA Working Group
Meeting with European Society for Paediatric Oncology
20 Jun 2025 · Discussion on the identification of clinical experts to participate in joint scientific consultations and joint clinical assessments under the EU Regulation on health technology assessment.
Meeting with Novartis International AG
3 Jun 2025 · The role of the Commission was here to facilitate the exchange between Novartis and the HTA Coordination Group Chairs about a medicinal product sent for joint clinical assessment
Meeting with European Confederation of Pharmaceutical Entrepreneurs
27 Mar 2025 · EU HTA regulation
Meeting with Global Health Education Group LTD
17 Feb 2025 · Health workforce